ABSTRACT
Diverticulosis, its associated symptoms and complications are one of the most common pathologies of the gastrointestinal tract in more economically developed countries. Presence of diverticuli and their clinical consequences can be divided into four categories: 1) diverticulosis, i.e. an asymptomatic presence of diverticuli that are usually found by accident 2) symptomatic uncomplicated diverticulosis 3) diverticulitis (acute uncomplicated diverticulitis) 4) complications of diverticulitis (conditions requiring hospital stay). The aim of this study was to retrospectively analyze the efficacy of rifaximin in preventing diverticulitis in patients visiting proctology clinics. The diagnostic criterium for diverticulosis was confirmation by colonoscopy, barium enema or CT colography (virtual colonoscopy) as well as history of at least one documented episode of diverticulosis. History of diverticulosis was evaluated based on medical records, clinical symptoms, elevated level of CRP (>5.0) and/or diagnostic imaging (ultrasound, CT). After setting strict exclusion criteria, 248 patients were qualified for the study out of 686, and they were later divided into two groups: control group (group I - 145 patients) and studied group (group II - 103 patients receiving rifaximin prophylaxis). Diverticulitis rate was comparable in both groups over a period of 6 months before study (p = 0.1306) and 6 months of treatment (p=0.3044). Between the 6th and 12th month of treatment, a significantly lower rate of diverticulitis was noted in the group receiving rifaximin compared to control group (p<0.0001). Patients receiving rifaximin reported higher quality of life (which was assessed using the VAS scale) compared to control group after 12 months. The results confirmed the efficacy of riaximin in prevention of diverticulitis, even in the scheme of repeated courses every 3 months. Not only did application of rifaximin lower the rate of diverticulitis and its complications in patients after an episode of diverticulitis, but also it improved the patients' quality of life. It seems that diverticulitis prophylaxis based on rifaximin can be economically efficient, however, it requires further research.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Diverticulitis, Colonic/drug therapy , Gastrointestinal Agents/therapeutic use , Quality of Life , Rifamycins/therapeutic use , Diverticulitis, Colonic/psychology , Female , Humans , Male , Retrospective Studies , Rifaximin , Severity of Illness Index , Treatment OutcomeABSTRACT
We examined a group of 83 patients (57 children and 26 adults) with thin basement membrane disease and 17 patients with Alport syndrome. We compared the clinical data and, above all, the morphological patterns of both disease entities, with particular focus on not very advanced changes which might lead to a misdiagnosis due to the non-detection of the early stages of Alport syndrome.
Subject(s)
Basement Membrane/pathology , Kidney Diseases/diagnosis , Nephritis, Hereditary/diagnosis , Adolescent , Adult , Aged , Basement Membrane/ultrastructure , Child , Child, Preschool , Diagnosis, Differential , Female , Fluorescent Antibody Technique , Humans , Kidney Diseases/pathology , Male , Microscopy, Electron, Transmission , Middle Aged , Young AdultABSTRACT
The aim of this study was to apply the spatial visualization method of digital images to quantitative analysis of pro-inflammatory cytokines IL-1, IL-6 and TNF-α in various segments of large bowel excised because of colitis ulcerosa in relation with selected clinical symptoms. Our preliminary study included 17 patients having undergone restorative proctocolectomy. Immunohistochemistry was performed for IL-1, IL-6 and TNF-α. The area fraction and intensity fraction of the cytokines studied were determined by digital image analysis. The results were then categorized using Alfred Immunohistochemistry Score. The expression of IL-1, IL-6 and TNF-α was significantly higher in the rectum than in colonic segments (p<0.01), and was associated with the patients' clinical condition. The method of quantitative immunohistochemistry presented here allows for searching associations between the expression of biomarkers and clinical symptoms. Evaluation of inflammatory cytokines could be recommended in the active stage of the disease with present symptoms of bloody and mucus stools. A higher expression of IL-1, IL-6 and TNF in samples beyond large intestine correlates with an intensified clinical course of the disease. In patients without bleeding and mucus symptoms present in stools, no significant correlations were found. Therefore, the assessment of cytokines during remission or clinically silent stage might not be useful.
Subject(s)
Colitis, Ulcerative/immunology , Colon/immunology , Image Interpretation, Computer-Assisted , Immunohistochemistry , Inflammation Mediators/analysis , Intestinal Mucosa/immunology , Adult , Aged , Biomarkers/analysis , Colectomy , Colitis, Ulcerative/pathology , Colitis, Ulcerative/surgery , Colon/pathology , Disease Progression , Female , Humans , Interleukin-1/analysis , Interleukin-6/analysis , Intestinal Mucosa/pathology , Male , Middle Aged , Predictive Value of Tests , Severity of Illness Index , Tumor Necrosis Factor-alpha/analysis , Young AdultABSTRACT
Development of dysplastic lesions that may potentially lead to cancer is sometimes reported within the ileal pouches. Dysplasia is in turn associated with increased expression of proliferation indices. The goal of this study was to evaluate the mitotic activity and possible expression of p53 in the epithelium within the ileal pouches in patients with chronic ulcerative colitis. The study involved archive material consisting of ileal pouches surgically removed from 17 patients diagnosed with ulcerative colitis. Several specimens were collected from each pouch. The immunohistochemistry (Ki-67 and p53 protein) control group (14 cases) consisted of the resection line specimens of colons removed due to colorectal adenocarcinoma. Intensity of the expression of the markers under study within the inflammatory infiltrates was assessed using a 5-point scale proposed by Berstein et al. Ki-67 expression was observed in all studied patients with marked intensity (Bernstein scale score +3, +4). Protein p53 expression was observed only in eight patients, and was mostly of low intensity (Bernstein scale score +1, +2). Immunohistochemical results confirmed the histopathological results that revealed dysplastic lesions, which are often an indication for radical procedures in ulcerative colitis patients. Our results suggest the usefulness of these examinations, also in the ileal pouch material.
Subject(s)
Colonic Pouches/pathology , Precancerous Conditions/metabolism , Tumor Suppressor Protein p53/biosynthesis , Adult , Aged , Colitis, Ulcerative/surgery , Female , Humans , Immunohistochemistry , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Ki-67 Antigen/analysis , Ki-67 Antigen/biosynthesis , Male , Middle Aged , Pouchitis/diagnosis , Pouchitis/metabolism , Pouchitis/pathology , Precancerous Conditions/diagnosis , Tumor Suppressor Protein p53/analysisABSTRACT
UNLABELLED: Restorative proctocolectomy is considered a surgical treatment of choice in ulcerative colitis (UC) and familial adenomatous polyposis (FAP).The aim of the study was to evaluate postoperative complications in patients who underwent surgery for familial adenomatous polyposis and ulcerative colitis, on the basis of a retrospective data analysis. MATERIAL AND METHODS: Data of 138 patients after restorative proctocolectomy performed between 1985 and 2008 were collected at routine follow-up visits in 2004-2008. We evaluated the presence of pouchitis, the degree of ileal pouch mucosa atrophy, the presence of ileal pouch mucosal metaplasia, the presence of ileal pouch malignancies, the necessity for diverting ileostomy, the necessity for pouch resection, and severe faecal incontinence. RESULTS: Complications were observed in 45 (32.4%) patients. Thirty-seven patients developed pouchitis (26.6%). Low-degree dysplasia, severe dysplasia or malignancies were observed in total in 20 patients (14.4%). Six (4.3%) operated patients developed other analysed complications. CONCLUSIONS: The most common complications of restorative proctocolectomy were dysplasia and pouchitis. The most common complication in patients operated for UC was pouchitis. The low observed incidence of intestinal pouchitis may be attributed to the implemented prophylaxis of inflammation. Dysplasia was the most common complication in patients undergoing proctocolectomy for FAP. Due to an increased risk of dysplastic lesions as compared with UC patients, careful endoscopic follow-up examinations are obligatory in this patient group. Other analysed complications were uncommon and were mostly a consequence of chronic pouchitis. Clinical symptoms of pouch-related problems were similar in both analysed groups.
Subject(s)
Adenomatous Polyposis Coli/surgery , Colitis, Ulcerative/surgery , Colonic Pouches/adverse effects , Pouchitis/etiology , Proctocolectomy, Restorative/adverse effects , Adult , Anal Canal/surgery , Colonic Pouches/statistics & numerical data , Female , Follow-Up Studies , Humans , Intestinal Obstruction/etiology , Middle Aged , Poland/epidemiology , Postoperative Complications/epidemiology , Pouchitis/therapy , Proctocolectomy, Restorative/methods , Quality of Life , Retrospective Studies , Risk Factors , Treatment Outcome , Young AdultABSTRACT
UNLABELLED: Screening of the colon cancer seems to be important to improve the results of the surgical treatment. There are different screening programs, the most common use the fecal occult blood (FOB) tests or colonoscopy. THE AIM OF THE STUDY: was to evaluate the results of the colon cancer screening based on the FOB test and perform the algorhytm improving the effectiveness of the screening. MATERIAL AND METHODS: 941 patients with the positive results of the FOB (immunochromatographic method) test were investigated. In all cases the rectosigmoidoscopy for the detection of the lower GI tract pathology was done. 312 patients were qualified to colonoscopy. RESULTS: Adenomatous polyps and adenocarcinomas were detected in 116 patients. There was no correlation between clinical symptoms and the colorectal cancer. The colorectal cancer was recognized statistically more common at the patients with previous detected neoplasia, in the colon and other organs, with hereditary nonpolyposis colorectal cancer and with inflammatory bowel diseases. CONCLUSIONS: The colorectal cancer screening based on the FOB can be effective in the early recognition of the bowel malignancy. The previous questionnaire can eliminate from the FOB screening the patients without indications (previously done colonoscopy or barium enema) or with directly indications for colonoscopy.